Description

6-Isoquinolinecarboxylic Acid, 2-(6-Benzofuranylcarbonyl)-5,7-Dichloro-1,2,3,4-Tetrahydro- is a high-purity, complex heterocyclic building block of significant interest in advanced organic synthesis. This compound matters for its role as a key intermediate in the development of novel pharmacologically active molecules, particularly within medicinal chemistry research. It is needed by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and fine chemical industries seeking to create new compounds with targeted biological activities.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of potential new drug candidates, especially those targeting central nervous system (CNS) disorders or infectious diseases.
• Medicinal Chemistry Research: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Agrochemical Development: Acts as a building block for creating novel active ingredients with herbicidal or pesticidal properties.
• Fine Chemical Synthesis: Employed in the multi-step synthesis of complex organic molecules for advanced material science or specialty chemical applications.
• Biochemical Probe Development: Utilized in the design and synthesis of molecular probes for studying enzyme function or cellular pathways.

Basic Information

Product Name	6-Isoquinolinecarboxylic Acid, 2-(6-Benzofuranylcarbonyl)-5,7-Dichloro-1,2,3,4-Tetrahydro-
CAS No.	2129597-34-6
Molecular Formula	C19H13Cl2NO4
Molecular Weight	390.22 g/mol
Synonyms	2-(Benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid; 5,7-Dichloro-2-(6-benzofuranylcarbonyl)-1,2,3,4-tetrahydro-6-isoquinolinecarboxylic Acid; 2-(6-Benzofurancarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinecarboxylic Acid; 2129597-34-6; Tetrahydroisoquinoline-6-carboxylic acid derivative
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. Each batch is characterized using advanced analytical techniques to confirm identity, purity, and consistency. Certificates of Analysis (COA) detailing specific results for purity, related substances, and residual solvents are available upon request. We adhere to cGMP principles for the manufacture of advanced pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed in a dry environment to prevent moisture absorption. Handle and store in accordance with all applicable regulations.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Meets ICH guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.